{"name":"Caregen Co. Ltd.","slug":"caregen-co-ltd","ticker":"","exchange":"","domain":"","description":"Caregen Co. Ltd. is a biotechnology company focused on developing innovative therapies, with a marketed drug and several candidates in early clinical stages. The company's pipeline includes treatments for various conditions, showcasing its commitment to advancing patient care through research and development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Aflibercept Injection [Eylea]","genericName":"Aflibercept Injection [Eylea]","slug":"aflibercept-injection-eylea","indication":"Neovascular (wet) age-related macular degeneration (AMD)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CG-SpikeDown, intranasal formulation","genericName":"CG-SpikeDown, intranasal formulation","slug":"cg-spikedown-intranasal-formulation","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Aflibercept Injection [Eylea]","genericName":"Aflibercept Injection [Eylea]","slug":"aflibercept-injection-eylea","phase":"marketed","mechanism":"Aflibercept is a soluble decoy receptor that binds and neutralizes vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), inhibiting their signaling to reduce abnormal blood vessel growth and vascular permeability in the eye.","indications":["Neovascular (wet) age-related macular degeneration (AMD)","Macular edema following retinal vein occlusion (RVO)","Diabetic macular edema (DME)","Diabetic retinopathy"],"catalyst":""},{"name":"CG-SpikeDown, intranasal formulation","genericName":"CG-SpikeDown, intranasal formulation","slug":"cg-spikedown-intranasal-formulation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-16","type":"pipeline","source":"simplywall.st","summary":"Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - simplywall.st","headline":"Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5BbVp1cTRDQ2h0WDNnV2hwMGVBUEprSGZ5M09BNHlWRGpBM2VraTNWc1BOaFFUek1RZ1g1WkN0ckM0RXRZNlVKTXo4UVZBXy12cWxV?oc=5","date":"2025-10-14","type":"pipeline","source":"벤처스퀘어","summary":"Caregen Signs Peptide Technology Transfer MOU with India's Top Three Pharmaceutical Companies - 벤처스퀘어","headline":"Caregen Signs Peptide Technology Transfer MOU with India's Top Three Pharmaceutical Companies - 벤처스퀘어","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE42M0p2SXNDaU85VWg2VmFzanhwM1FKSGhrdTZ2aWFXX1J4NGhrYlFfOVlFY0RLQ0FqQ2xoSVpCX3F5YTdvVUZKSzNyRXhLZERodHZr?oc=5","date":"2025-10-13","type":"deal","source":"벤처스퀘어","summary":"Caregen Signs Strategic Partnership with Unider Pharmaceuticals - 벤처스퀘어","headline":"Caregen Signs Strategic Partnership with Unider Pharmaceuticals - 벤처스퀘어","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBTTE9VWENmdjhhQ3ZHQ0xBSXEyZnNUOERaZ1pXZ2FnaXJHaUlzSHFNSUtmTnlJYmhucFRVbFlWdnZEaG43dHRmby0xbGp0MTJZR203NEhyczVDdnVZVVZOZERDSGVQcFNpUmJRbndoS0lsLU5P?oc=5","date":"2025-07-16","type":"pipeline","source":"Businesskorea","summary":"Caregen Completes Registration of Oral GLP-1 Peptide ‘Korglutide’ in Ecuador - Businesskorea","headline":"Caregen Completes Registration of Oral GLP-1 Peptide ‘Korglutide’ in Ecuador","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOcWZfR0ROWmtCaHc0LXhNOUhOeG53enZSbWFVVHlaMDQ4dUxIdTNpdWRtWDNXMnJlSklpUEctTDNFTS1FWlh1bFJzWllqLXpqcmdDMEtBaTg4dDJlYW00MTBQSUVvTVBCYWg2UjZnelE0UDNtMXRlRmRIQ0tSX1MzTkVFdEJETzNoQmxaa1JFR25vOEFLOHhUbU9ydjEyd3lfak9fU1JvNVNMNGFudG9rSGxGSjFfaXpXS3M3MFlfS0U5Z3ZFVUZv?oc=5","date":"2025-02-28","type":"pipeline","source":"BioSpace","summary":"Pharmaceutical Contract Sales Organizations Market Size to Hit USD 26.24 Billion by 2034 - BioSpace","headline":"Pharmaceutical Contract Sales Organizations Market Size to Hit USD 26.24 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQU2RVTEF6dGdnTWdXLUZHcV9KWS1GZlBVdmtZMkliNnZacWNaN1Q3WWp2WXM2RjhiVFg3bVRlUlk0bndiczFDOTBQdS0wcGViZElLY0hMVXZWQ29jaVRGMHhTdVEwZVRreFV3WGZtOXZQcjRjNFVQX3dWTmEySGtPN3ZQRWMwRjkxNzloTS14S3ExemEyM2UteGZTWXZ4MlFLcE8yeEtBTGxSUQ?oc=5","date":"2024-12-04","type":"pipeline","source":"Precedence Research","summary":"Akums collaborates with Caregen to transform Indias cosmeceuticals - Precedence Research","headline":"Akums collaborates with Caregen to transform Indias cosmeceuticals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-12-02","type":"deal","source":"ET Edge Insights","summary":"Akums Drugs & Pharmaceuticals partners with Caregen Co., Ltd. to launch specialty nutraceuticals and differentiated cosmeceuticals in India - ET Edge Insights","headline":"Akums Drugs & Pharmaceuticals partners with Caregen Co., Ltd. to launch specialty nutraceuticals and differentiated cosm","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-12-02","type":"pipeline","source":"ET Pharma","summary":"Akums and Caregen to develop Nutraceuticals and Cosmeceuticals in India - ET Pharma","headline":"Akums and Caregen to develop Nutraceuticals and Cosmeceuticals in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOeF9sUll2ZWVsVUpoWkN6ZGp2c3J1RThPdUVnZWtQQ3JpQzVTMUM5Q0hZUlFMMEZYWDlWQldpVV9JWDhVUGx0OFRsUmszUzhlRXNXZWtNZDFKTGhzMjlVaU01anNlM1N4SzhYXzd3LUFGYWpqbEhGNlpFbWNlS1FpcDhlZHhCaFhRWXlacTNzRnpDNm44SnJZWDFKVlNLMTdjdVpqcFpGa9IBrAFBVV95cUxOYVZ3X01yXzB0SkxmSjNrYzktSmhkSU0wMmxXOGsyNS1vd0ppOENxZUZCZkVFcVJOZ0dyRWt0ZWR5ZWRjRHpYVjBXanR2TWRCdnJ2WGZ3Q0VHT0k5M1Bzb01aUWpjTzYtSkpNMHNsc3Y1ejRQSXFpT3dRMXplblNSQVZ4ZHZfOGRJdVBsOTJEWTVHNElMZDVaUTRPRFB2VnRvbHg1WGF3UzR6STBM?oc=5","date":"2024-11-28","type":"deal","source":"Express Pharma","summary":"Akums, Caregen partner to launch nutraceuticals and cosmeceuticals in India - Express Pharma","headline":"Akums, Caregen partner to launch nutraceuticals and cosmeceuticals in India","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}